Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
Crossref DOI link: https://doi.org/10.1007/s00266-023-03306-1
Published Online: 2023-03-23
Published Print: 2023-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Yan
Fang, Fang
Lai, Wei
Li, Chengxin
Li, Li
Liu, Quanzhong
Lu, Jianyun
Pang, Xiaowen
Sun, Jiaming
Shi, Xiaofeng
Picaut, Philippe
Prygova, Inna
Andriopoulos, Bill
Sun, Qiuning
Text and Data Mining valid from 2023-03-23
Version of Record valid from 2023-03-23
Article History
First Online: 23 March 2023